Top

Supportive Care in Cancer

Published in:

01-03-2013 | Original Article

Cardiorespiratory and neuromuscular deconditioning in fatigued and non-fatigued breast cancer survivors

Authors: Sarah E. Neil, Riggs J. Klika, S. Jayne Garland, Donald C. McKenzie, Kristin L. Campbell

Published in: Supportive Care in Cancer | Issue 3/2013

Abstract

Purpose

Fatigue is one of the most commonly reported side effects during treatment for breast cancer and can persist following treatment completion. Cancer-related fatigue after treatment is multifactorial in nature, and one hypothesized mechanism is cardiorespiratory and neuromuscular deconditioning. The purpose of this study was to compare cardiorespiratory and neuromuscular function in breast cancer survivors who had completed treatment and met the specified criteria for cancer-related fatigue and a control group of breast cancer survivors without fatigue.

Methods

Participants in the fatigue (n = 16) and control group (n = 11) performed a maximal exercise test on a cycle ergometer for determination of peak power, power at lactate threshold, and VO₂ peak. Neuromuscular fatigue was induced with a sustained submaximal contraction of the right quadriceps. Central fatigue (failure of voluntary activation) was evaluated using twitch interpolation, and peripheral fatigue was measured with an electrically evoked twitch.

Results

Power at lactate threshold was lower in the fatigue group (p = 0.05). There were no differences between groups for power at lactate threshold as percentage of peak power (p = 0.10) or absolute or relative VO₂ peak (p = 0.08 and 0.33, respectively). When adjusted for age, the fatigue group had a lower power at lactate threshold (p = 0.02) and absolute VO₂ peak (p = 0.03). There were no differences between groups in change in any neuromuscular parameters after the muscle-fatiguing protocol.

Conclusions

Findings support the hypothesis that cardiorespiratory deconditioning may play a role in the development and persistence of cancer-related fatigue following treatment. Future research into the use of exercise training to reduce cardiorespiratory deconditioning as a treatment for cancer-related fatigue is warranted to confirm these preliminary findings.

Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(Suppl 1):4–10PubMedCrossRef

Holley S (2000) Cancer-related fatigue. Suffering a different fatigue. Cancer Pract 8(2):87–95PubMedCrossRef

Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18(4):743–753PubMed

Dimeo FC (2001) Effects of exercise on cancer-related fatigue. Cancer 92(6 Suppl):1689–1693PubMedCrossRef

Geinitz H, Zimmermann FB, Thamm R, Keller M, Busch R, Molls M (2004) Fatigue in patients with adjuvant radiation therapy for breast cancer: long-term follow-up. J Cancer Res Clin Oncol 130(6):327–333. doi:10.1007/s00432-003-0540-9 PubMedCrossRef

Al-Majid S, McCarthy DO (2001) Cancer-induced fatigue and skeletal muscle wasting: the role of exercise. Biol Res Nurs 2(3):186–197PubMedCrossRef

Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K (2005) Management of cancer-related fatigue. Cancer Invest 23(3):229–239PubMedCrossRef

Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR (2009) Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 10(6):598–605. doi:10.1016/S1470-2045(09)70031-2 PubMedCrossRef

Irwin ML, Crumley D, McTiernan A, Bernstein L, Baumgartner R, Gilliland FD, Kriska A, Ballard-Barbash R (2003) Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97(7):1746–1757. doi:10.1002/cncr.11227 PubMedCrossRef

10.

Wasserman K (1987) Determinants and detection of anaerobic threshold and consequences of exercise above it. Circulation 76(6 Pt 2):VI29–VI39PubMed

11.

Wasserman K, Beaver WL, Whipp BJ (1990) Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulation 81(1 Suppl):II14–II30PubMed

12.

Faude O, Kindermann W, Meyer T (2009) Lactate threshold concepts: how valid are they? Sports Med (Auckland, NZ) 39(6):469–490CrossRef

13.

Peterson BMR, Chris P, Dallow K, Hayward R, Schneider CM (2011) Cancer-related fatigue and the impact of psychological and physiological variables. Med Sci Sports Exerc 43(5):562

14.

Yavuzsen T, Davis MP, Ranganathan VK, Walsh D, Siemionow V, Kirkova J, Khoshknabi D, Lagman R, LeGrand S, Yue GH (2009) Cancer-related fatigue: central or peripheral? J Pain Symptom Manage 38(4):587–596. doi:10.1016/j.jpainsymman.2008.12.003 PubMedCrossRef

15.

Monga U, Jaweed M, Kerrigan AJ, Lawhon L, Johnson J, Vallbona C, Monga TN (1997) Neuromuscular fatigue in prostate cancer patients undergoing radiation therapy. Arch Phys Med Rehabil 78(9):961–966PubMedCrossRef

16.

Gandevia SC (2001) Spinal and supraspinal factors in human muscle fatigue. Physiol Rev 81(4):1725–1789PubMed

17.

Enoka RM, Duchateau J (2008) Muscle fatigue: what, why and how it influences muscle function. J Physiol 586(1):11–23. doi:10.1113/jphysiol.2007.139477 PubMedCrossRef

18.

Evans WJ, Lambert CP (2007) Physiological basis of fatigue. Am J Phys Med Rehabil 86(1 Suppl):S29–S46PubMedCrossRef

19.

Cella D, Davis K, Breitbart W, Curt G (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19(14):3385–3391PubMed

20.

Schneider J, Dudziak R, Westphal K, Vettermann J (1997) The i-STAT analyzer. A new, hand-held device for the bedside determination of hematocrit, blood gases, and electrolytes. Anaesthesist 46(8):704–714PubMedCrossRef

21.

Patel KV (2008) Epidemiology of anemia in older adults. Semin Hematol 45(4):210–217. doi:10.1053/j.seminhematol.2008.06.006 PubMedCrossRef

22.

Tanner RK, Fuller KL, Ross ML (2010) Evaluation of three portable blood lactate analysers: lactate pro, lactate scout and lactate plus. Eur J Appl Physiol 109(3):551–559. doi:10.1007/s00421-010-1379-9 PubMedCrossRef

23.

Klika RJ, Golik KS, Drum SN, Callahan KE, Thorland WG (2011) Comparison of physiological response to cardiopulmonary exercise testing among cancer survivors and healthy controls. Eur J Appl Physiol 111(6):1167–1176. doi:10.1007/s00421-010-1749-3 PubMedCrossRef

24.

American College of Sports M (2009) ACSM's guidelines for exercise testing and prescription, vol 8. Lippincott, Williams and Wilkins, Philadelphia, pp 91–134

25.

Coyle EF, Martin WH, Ehsani AA, Hagberg JM, Bloomfield SA, Sinacore DR, Holloszy JO (1983) Blood lactate threshold in some well-trained ischemic heart disease patients. J Appl Physiol Respir Environ Exerc Physiol 54(1):18–23

26.

Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G (1997) Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 15(3):974–986PubMed

27.

Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13(2):63–74PubMedCrossRef

28.

Beck AT, Steer RA (1984) Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40(6):1365–1367PubMedCrossRef

29.

Taylor HL, Jacobs DR Jr, Schucker B, Knudsen J, Leon AS, Debacker G (1978) A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 31(12):741–755PubMedCrossRef

30.

Drouin JS, Young TJ, Beeler J, Byrne K, Birk TJ, Hryniuk WM, Hryniuk LE (2006) Random control clinical trial on the effects of aerobic exercise training on erythrocyte levels during radiation treatment for breast cancer. Cancer 107(10):2490–2495. doi:10.1002/cncr.22267 PubMedCrossRef

31.

Dimeo F, Schwartz S, Wesel N, Voigt A, Thiel E (2008) Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment. Ann Oncol 19(8):1495–1499. doi:10.1093/annonc/mdn068 PubMedCrossRef

32.

Lane RJ, Barrett MC, Woodrow D, Moss J, Fletcher R, Archard LC (1998) Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 64(3):362–367PubMedCrossRef

33.

Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498–S504PubMed

34.

Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4(2):87–100. doi:10.1007/s11764-009-0110-5 PubMedCrossRef

35.

Hurley MV, Rees J, Newham DJ (1998) Quadriceps function, proprioceptive acuity and functional performance in healthy young, middle-aged and elderly subjects. Age Ageing 27(1):55–62PubMedCrossRef

36.

Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426. doi:10.1249/MSS.0b013e3181e0c112 PubMedCrossRef

Title: Cardiorespiratory and neuromuscular deconditioning in fatigued and non-fatigued breast cancer survivors
Authors: Sarah E. Neil
Riggs J. Klika
S. Jayne Garland
Donald C. McKenzie
Kristin L. Campbell
Publication date: 01-03-2013
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 3/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-012-1600-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2013

The fall rate of older community-dwelling cancer patients

Health-related quality of life, depression, and sexual function in testicular cancer survivors in a developing country: a Serbian experience

Clinical usefulness of the Frontal Assessment Battery at bedside (FAB) for elderly cancer patients

Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center

Somatic symptoms in cancer patients trajectory over 12 months and impact on functional status and disability

The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer